{"id":"https://openalex.org/W4400965813","doi":"https://doi.org/10.21037/tcr-24-20","title":"CDK4/6 inhibition to resensitize BRAF/EGFR inhibitor in patient-derived BRAF/PTEN-mutant colon cancer cells","display_name":"CDK4/6 inhibition to resensitize BRAF/EGFR inhibitor in patient-derived BRAF/PTEN-mutant colon cancer cells","publication_year":2024,"publication_date":"2024-07-01","ids":{"openalex":"https://openalex.org/W4400965813","doi":"https://doi.org/10.21037/tcr-24-20","pmid":"https://pubmed.ncbi.nlm.nih.gov/39145064","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11319972"},"language":"en","primary_location":{"id":"doi:10.21037/tcr-24-20","doi":"https://doi.org/10.21037/tcr-24-20","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr-24-20","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.21037/tcr-24-20","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062157181","display_name":"Sung Hee Lim","orcid":"https://orcid.org/0000-0003-0845-9994","observed_orcids":["https://orcid.org/0000-0003-0845-9994"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sung Hee Lim","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Korea","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073142902","display_name":"Song-Yi Lee","orcid":"https://orcid.org/0009-0009-8123-4100","observed_orcids":["https://orcid.org/0009-0009-8123-4100"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Song-Yi Lee","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Korea","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013311116","display_name":"Jung Yong Hong","orcid":"https://orcid.org/0000-0003-1363-9332","observed_orcids":["https://orcid.org/0000-0003-1363-9332"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jung Yong Hong","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Korea","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019406140","display_name":"Jeeyun Lee","orcid":"https://orcid.org/0000-0002-4911-6165","observed_orcids":["https://orcid.org/0000-0002-4911-6165"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jeeyun Lee","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Korea","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026351538","display_name":"Seung Tae Kim","orcid":"https://orcid.org/0000-0001-7335-1846","observed_orcids":["https://orcid.org/0000-0001-7335-1846"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Seung Tae Kim","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Korea","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5026351538"],"corresponding_institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"],"apc_list":null,"apc_paid":null,"fwci":1.2929,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.81578051,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":98},"biblio":{"volume":"13","issue":"7","first_page":"3695","last_page":"3703"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk4-6-inhibition","display_name":"CDK4/6 inhibition","score":0.8489999771118164},{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.972000002861023},{"id":"https://openalex.org/keywords/braf-mutant-colorectal-cancer","display_name":"BRAF-mutant colorectal cancer","score":0.8840000033378601},{"id":"https://openalex.org/keywords/pten-mutation","display_name":"PTEN mutation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/encorafenib","display_name":"encorafenib","score":0.9739999771118164},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/egfr-inhibitor-resistance","display_name":"EGFR inhibitor resistance","score":0.6830000281333923},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.6809999942779541},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/synergistic-effect","display_name":"synergistic effect","score":0.5350000262260437},{"id":"https://openalex.org/keywords/metastatic-colon-cancer","display_name":"metastatic colon cancer","score":0.7179999947547913},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.7910000085830688}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.7900197505950928},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6571899652481079},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.6564849615097046},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6127933263778687},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.6086742281913757},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5865439176559448},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.5633530616760254},{"id":"https://openalex.org/C2910786375","wikidata":"https://www.wikidata.org/wiki/Q604261","display_name":"Viral Oncogene","level":3,"score":0.507930338382721},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.506895124912262},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.4654539227485657},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44812649488449097},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4167238473892212},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3397752046585083},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24210062623023987},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.22066161036491394},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.148959219455719},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.14430102705955505},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.08554571866989136},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06448432803153992},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.06264698505401611}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.21037/tcr-24-20","doi":"https://doi.org/10.21037/tcr-24-20","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr-24-20","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11319972","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11319972","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11319972/pdf/tcr-13-07-3695.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transl Cancer Res","raw_type":"Text"},{"id":"pmid:39145064","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39145064","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational cancer research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.21037/tcr-24-20","doi":"https://doi.org/10.21037/tcr-24-20","is_oa":true,"landing_page_url":"https://doi.org/10.21037/tcr-24-20","pdf_url":null,"source":{"id":"https://openalex.org/S2764965054","display_name":"Translational Cancer Research","issn_l":"2218-676X","issn":["2218-676X","2219-6803"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2574390382","display_name":null,"funder_award_id":"RS-2023-00222838","funder_id":"https://openalex.org/F4320320671","funder_display_name":"National Research Foundation"},{"id":"https://openalex.org/G3694807721","display_name":null,"funder_award_id":"RS-2023-00222838","funder_id":"https://openalex.org/F4320328359","funder_display_name":"Ministry of Science and ICT, South Korea"}],"funders":[{"id":"https://openalex.org/F4320308085","display_name":"Massachusetts Department of Agricultural Resources","ror":"https://ror.org/03wjj7779"},{"id":"https://openalex.org/F4320320671","display_name":"National Research Foundation","ror":"https://ror.org/05s0g1g46"},{"id":"https://openalex.org/F4320328359","display_name":"Ministry of Science and ICT, South Korea","ror":"https://ror.org/01wpjm123"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400965813.pdf","grobid_xml":"https://content.openalex.org/works/W4400965813.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1854233595","https://openalex.org/W1933326574","https://openalex.org/W2033499186","https://openalex.org/W2049282019","https://openalex.org/W2074473619","https://openalex.org/W2074918415","https://openalex.org/W2100589633","https://openalex.org/W2103562758","https://openalex.org/W2104682649","https://openalex.org/W2108068107","https://openalex.org/W2108468456","https://openalex.org/W2111369086","https://openalex.org/W2114048774","https://openalex.org/W2124662474","https://openalex.org/W2127150495","https://openalex.org/W2131413118","https://openalex.org/W2134142320","https://openalex.org/W2135454464","https://openalex.org/W2155311724","https://openalex.org/W2163188200","https://openalex.org/W2166229764","https://openalex.org/W2471247568","https://openalex.org/W2598954950","https://openalex.org/W2600199136","https://openalex.org/W2603299281","https://openalex.org/W2760461398","https://openalex.org/W2791410762","https://openalex.org/W2893221764","https://openalex.org/W2921680067","https://openalex.org/W2939903074","https://openalex.org/W2948069739","https://openalex.org/W2977895282","https://openalex.org/W2985568914","https://openalex.org/W3123642801","https://openalex.org/W3134887329","https://openalex.org/W3175183925","https://openalex.org/W3193135661","https://openalex.org/W4200501736","https://openalex.org/W4281757062"],"related_works":["https://openalex.org/W2272568747","https://openalex.org/W3005340960","https://openalex.org/W2473420009","https://openalex.org/W2528229149","https://openalex.org/W4413007467","https://openalex.org/W4409652505","https://openalex.org/W3132428231","https://openalex.org/W2784333640","https://openalex.org/W2493930640","https://openalex.org/W1980608547"],"abstract_inverted_index":{"Background:":[0],"In":[1],"v-raf":[2],"murine":[3],"sarcoma":[4],"viral":[5],"oncogene":[6],"homolog":[7],"B1":[8],"(BRAF)-mutant":[9],"colorectal":[10],"cancer":[11,85],"(CRC),":[12],"encorafenib-cetuximab":[13,118,158,177,188,244],"has":[14],"been":[15],"established":[16,74],"as":[17],"standard":[18],"second-line":[19],"therapy,":[20],"but":[21],"not":[22],"all":[23],"patients":[24],"respond":[25],"and":[26,125,140,212,276],"the":[27,55,60,149,157,172,198,220,224,231,260,264],"duration":[28],"of":[29,54,165,194,227],"response":[30],"is":[31,42,57],"relatively":[32],"short.":[33],"Overcoming":[34],"intrinsic":[35],"or":[36],"acquired":[37],"resistance":[38,61,100,147],"to":[39,58,68,148,156,168,176,197,247],"BRAF/EGFR":[40,69,150,265],"inhibitors":[41],"crucial":[43],"for":[44,98,273],"enhancing":[45],"treatment":[46,96,271],"outcomes":[47],"in":[48,63,106,119,182],"metastatic":[49,83],"BRAF-mutated":[50,107],"CRC.":[51,278],"The":[52,130,152],"aim":[53],"study":[56],"investigate":[59],"mechanisms":[62],"BRAF-mutant":[64],"CRC":[65],"patient":[66,80],"refractory":[67],"targeted":[70],"therapy.":[71],"Methods:":[72],"We":[73],"patient-derived":[75],"cells":[76],"(PDCs)":[77],"from":[78,144],"a":[79,122,162,179,183,190,240,250,269],"with":[81,117,121,209,243,249,263],"BRAF/PTEN-mutant":[82],"colon":[84],"who":[86],"progressed":[87],"rapidly":[88],"on":[89],"encorafenib":[90],"plus":[91,187],"cetuximab.":[92],"To":[93],"explore":[94],"potential":[95],"options":[97],"inherent":[99],"caused":[101],"by":[102],"simultaneous":[103],"PTEN":[104,135],"mutation":[105],"CRC,":[108],"we":[109],"conducted":[110],"cell":[111,215],"viability":[112,216],"assays":[113],"using":[114,230],"PDCs":[115,141,153,248],"treated":[116],"combination":[120,159,200,233],"cyclin-dependent":[123],"kinase-4":[124],"6":[126],"(CDK4/6)":[127],"inhibitor.":[128,151],"Results:":[129],"patient's":[131],"tumor":[132],"had":[133,239],"concurrent":[134,251],"loss-of-function":[136],"alteration":[137],"at":[138,161],"diagnosis":[139],"were":[142,154],"generated":[143],"ascites":[145],"after":[146],"resistant":[155],"even":[160],"high":[163],"concentration":[164],"cetuximab":[166,213],"(up":[167],"500":[169],"\u00b5g/mL).":[170],"Adding":[171],"CDK4/6":[173,261],"inhibitor,":[174],"ribociclib,":[175,210],"showed":[178,205,236],"synergistic":[180,241],"effect":[181,226,242],"proliferation":[184],"assay.":[185],"Ribociclib":[186],"represented":[189],"significantly":[191],"lower":[192],"expression":[193],"Ki-67":[195],"compared":[196],"dual":[199],"alone.":[201],"An":[202],"MTS":[203],"assay":[204],"that":[206,237,258],"triplet":[207,228],"therapy":[208,229],"encorafenib,":[211],"suppressed":[214],"more":[217],"efficiently":[218],"than":[219],"two-drug":[221],"combinations.":[222],"Investigating":[223],"combined":[225],"calculated":[232],"index":[234],"(CI)":[235],"ribociclib":[238],"when":[245],"applied":[246],"BRAF/PTEN":[252],"mutation.":[253],"Conclusions:":[254],"Our":[255],"results":[256],"suggest":[257],"combining":[259],"inhibitor":[262,266],"might":[267],"be":[268],"novel":[270],"strategy":[272],"concomitant":[274],"BRAF":[275],"PTEN-mutant":[277]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2024-07-25T00:00:00"}